drugset / Trial / NCT01496326

Osteoarthritis Topical Treatment

NCT01496326

Phase 2 Completed 75 enrolled BioChemics, Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

This is a phase 2a clinical trial performed to evaluate the efficacy of a topical treatment of ibuprofen compared to the use of a placebo topical treatment. A multi-center, double-blinded, randomized placebo controlled study. Study length: 14 days Dosing twice daily (b.i.d.)

Timeline

Start
2011-02
Primary completion
2011-08
Completion
2011-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Ibuprofen Small molecule 200 mg Topical

Indications